PROCESS AND DEVICE FOR SELECTIVELY TREATING INTERSTITIAL TISSUE
A method and apparatus for direct interstitial treatment of tissue, while preventing backflow and decreasing drainage of a flowable composition from an injected area, by using a catheter and/or a needle with single or multiple inflatable member(s) that stretches, dilates and compresses target tissue and allows for an improved interstitial deposition, distribution and retention of the flowable composition, drug(s), agent(s), or particle(s), into a body organ, fluid, tissue, or tumor, thereby increasing procedural safety and efficacy of direct interstitial therapies.
1 . A process for treating an interstitial tissue structure with an active agent comprising:
providing at least one catheter or needle having a proximal end and a distal end, a lumen assembly extending longitudinally from said proximal to said distal end, and at least one expandable dilation member distally located and adapted to be positioned at or within a treatment region within the solid tissue of a patient;
positioning said catheter distal end within or proximate to said treatment region;
expanding said at least one expandable dilation member, whereby interstitial tissue proximate said treatment region is dilated, compressed and stretched; and
contacting said active agent with interstitial tissue in said treatment region before, during or after expanding of said interstitial tissue;
whereby an enhanced and controlled spread and retention of the active agent is effectuated.
2 . The process of claim 2 wherein said step of expanding simultaneously prevents backflow of said active agent.
3 . The process of claim 1 further including providing a source of interstitial energy to said treatment region selected from the group consisting of thermal, sonic, light ablation, electroporation and combinations thereof.
4 . The process of claim 1 wherein said step of contacting is selected from the group consisting of local injection, regional or systemic injection, insertion within body cavities and combinations thereof.
5 . The process of claim 1 wherein said active agent is free or bound to a carrier to enable a controlled release, and is selected from the group consisting of saline solution, heating or cooling fluids, a photosensitizer, a radiosensitizer, a radioisotope, a sclerosing agent, radioseeds, thermoseeds, glue, a vaccine, a gene, an immunologic factor, a hormone, a cytotoxic agent, and combinations thereof.
6 . The process of claim 1 wherein said interstitial tissue structure is a benign or malignant tumor, or a dysfunctional zone of an organ or target tissue.
7 . The process of claim 6 wherein said interstitial tissue structure is a malignant tumor.
8 . The process of claim 7 wherein said active agent includes at least one cytotoxic agent.
9 . The process of claim 8 wherein said step of contacting said at least one cytotoxic agent with said dilated, compressed and stretched interstitial tissue includes delivering said cytotoxic agent to a particular region within said tumor including the tumor's margin, within critical areas for growth and expansion, and to areas exhibiting resistance to conventional therapies.
10 . The process of claim 1 including a step of identifying said treatment region by using sensors for sensing tissue parameters selected from the group consisting of electrical impedance, temperature, pressure, optical characteristics disposed at the distal end of the catheter and combinations thereof.
11 . The process of claim 1 wherein said steps of expanding and contacting are replicated in multiple cycles which are executed by a manual or automatic device.
12 . The process of claim 6 wherein said steps of expanding and contacting are carried out while essentially preventing flushing of tumor cells and preventing backflow of said active agent.
13 . An expandable injection system useful in the treatment of an interstitial tissue structure with at least one active agent comprising, in combination, a syringe or pump system, at least one inflatable member, and a needle or catheter constructed and arranged for interstitially contacting, manually or automatically, precisely measured amounts of said at least one active agent directly into a body tumor or tissue positioned at or within a treatment region within the solid tissue of a patient, while minimizing or preventing backflow of said active agent, and applying compression to said tissue structure to minimize or prevent drainage of said active agent.
14 . The expandable injection system of claim 12 wherein said system further includes means for contacting said interstitial tissue structure with a source of interstitial energy to said treatment region selected from the group consisting of thermal, sonic, light ablation, electroporation and combinations thereof.
15 . The expandable injection system of claim 14 wherein said active agent is selected from the group consisting of saline solution, heating or cooling fluids, a photosensitizer, a radiosensitizer, a radioisotope, a sclerosing agent, radioseeds, thermoseeds, glue, a vaccine, a gene, an immunologic factor, a hormone, a cytotoxic agent, and combinations thereof.
16 . The expandable injection system of claim 14 wherein said inflatable member is at least one expandable dilation member, constructed and arranged to dilate, compress and stretch said interstitial tissue proximate said treatment region whereby an enhanced and controlled spread and retention of the active agent is effectuated.
17 . The expandable injection system of claim 16 wherein said expandable dilation member is a unitary body which dilates, compresses and stretches said interstitial tissue proximate said treatment region while simultaneously preventing backflow of said active agent.
18 . The expandable injection system of claim 16 wherein said expandable dilation member comprises a first occlusion balloon surrounding a second occlusion balloon, said occlusion balloons arranged concentrically and defining a dosage region for retaining said active agent therebetween, wherein expansion of said second occlusion balloon expands said first occlusion balloon causing it to dilate, compress and stretch said interstitial tissue proximate said treatment region, and wherein active agent inserted within said dosage region is pressurized and forced into said dilated, compressed and stretched interstitial tissue.
19 . The expandable injection system of claim 18 wherein said first occlusion balloon is porous and said at least one active agent is released from the material by elution from pores.
20 . The expandable injection system of claim 13 wherein said catheter has a proximal and a distal end, a central portion including a first longitudinally extending lumen assembly having at least one opening on its proximal end adapted for transport of said at least one active agent to said distal end thereof, and further including means for expansion of said at least one expandable dilation member.
21 . The expandable injection system of claim 20 wherein said lumen assembly has a second longitudinally extending opening capable of communicating with said at least one expandable dilation member.
22 . The expandable injection system of claim 13 further including sensors for sensing tissue parameters selected from the group consisting of electrical impedance, temperature, pressure, optical characteristics disposed at the distal end of the catheter and combinations thereof.
23 . The expandable injection system of claim 13 wherein said means for interstitially contacting precisely measured amounts of said at least one active agent directly into said body tumor or tissue are adapted to replicate said contacting in multiple cycles.
24 . The process for treating an interstitial tissue structure with an active agent in accordance with claim 1 , further including a step of collapsing said expandable dilation member.
25 . The process for treating an interstitial tissue structure with an active agent in accordance with claim 1 , further including a step of retrieving and/or repositioning said catheter or needle.